Clinical Update - Debio 9902 SR in Alzheimer...(ready marketed AChE inhibitors by increa...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Clinical Update - Debio 9902 SR in Alzheimer's Disease
Date:3/4/2008
ready marketed AChE inhibitors, by increasing the compliance and -thus- the overall benefit for both the patients and their relatives.
About Debiopharm Group
Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.
Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm
has developed three products with global combined sales in excess of $2.6
billion in 2006.
For more information on Debiopharm Group, please visit: http://www.debiopharm.com.
Debiopharm S.A. Contacts
Herve Porchet
VP, Medical Affairs
Tel.: +41-21-321-01-11
Fax: +41-21-321-01-69
Emmanuel Tamches
Medical Director
Tel.: +41-21-321-01-11
Fax: +41-21-321-01-69
Additional Media Contacts
In London
Maitland
Brian Hudspith
Tel: +44-20-7379-5151
In New York
Russo Partners, LLC
Wendy Lau
Tel: +1-212-845-4272
Fax: +1-212-845-4260
wendy.lau@russopartnersllc.com
'/>"/>
| SOURCE Debiopharm Group Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Winnick Family Clinical Research Center Celebrates 6th Anniversary
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
4. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
5. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
6. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
7. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
8. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
9. Boston Scientific Announces Addition to Clinical Sciences Organization
10. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
11. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3... approval of an emergency,contraceptive with over-...nd older provides another option for preventing un...nformed or misinformed about how emergency,contrac... should to be able,to address these questions and ...regnancy., To address this issue, OBG Management ...
...ew Drug Products to Aida Pharmaceuticals, ...A, Calif., March 27 Aida,Pharmaceuticals, Inc. (O...as signed two share transfer agreements to acquire...obiology research institutes in the People,s,Repub...., Ltd. ("JSIM").,Aida Pharmaceutical,s subsidiary...
... Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq... commercial manufacture of PI-88. The Progen,manuf...will be retained as,a stand-alone business providi...e of drug development material. Progen expects the...t 12 to 18 months., Progen will maintain the manu...
Other Biology Technology:Publication Addresses Misconceptions About Emergency Contraception 2Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 2Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 3Progen Restructures Manufacturing and Drug Discovery Divisions 2Progen Restructures Manufacturing and Drug Discovery Divisions 3(Date:11/26/2009)...ogists have at last worked out a way of using reco...of bird populations. This is the first time sound ...lated into accurate estimates of bird species, pop...he British Ecological Society,s Journal of Applie...ld lead to a major advance in our ability to monit...
(Date:11/26/2009)...RIDGE, Mass. (November 26, 2009) Whitehead resear...for human cells to pinpoint specific genes and pro...in Science . , In most human cell cultures gene...e father and one from the mother. Gene inactivatio...n one copy is inactivated, the second copy usually...
(Date:11/26/2009)... (methicillin-resistant Staphylococcus Aureus ) a...lation as low-temperature plasma prototype devices...d unfailing bactericidal cocktails. , Two protot... disinfection of healthy skin (e.g. hands and feet...n pose a lethal threat; and another to shoot bacte...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 1Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 2Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 3Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 5139 1Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 5139 2Premier Research Appoints Troy W McCall Ph D as Chief Executive Officer 5134 1Premier Research Appoints Troy W McCall Ph D as Chief Executive Officer 5134 2...AKLAND, Calif., September 8, 2008For allergy suffe...to living without pets or curtains or anything tha...ox Company extends its Anywhere® product line ...Allergen Fabric Spray, a new product to help manag.... , Clorox® Anywhere® Anti-Allergen Fabr...
...ADISON, WI, September 2, 2008 -- A new interactive...ents and graduate students how herbicides are deve...ontana State University, has the seal of approval ...nces Education and is published in the 2008 issue... the market today were discovered by random search...
...n athlete,s ability to sweat may do more than keep...t of exercise-induced asthma (EIA), a common respi...rch appearing in the September issue of CHEST, t...f Chest Physicians (ACCP), shows that athletes wit...hose who do not have breathing problems. , Warre...
Other Biology News:The Clorox Company's new indoor allergen product reduces common indoor allergens up to 90 percent 2Athletes' 'sweat and tears' linked to asthma 2Athletes' 'sweat and tears' linked to asthma 3Rat Normal Multiple Tissue Array from BD Biosciences Pharmingen
S1 Nuclease from Invitrogen
Sperm viability Fluorometric (green) Assay Kit, LIVE/DEAD® from Molecular Probes (Invitrogen)
SlowFade Antifade Kit with DAPI from Molecular Probes (Invitrogen)
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |